Best price Capecitabine CAS NO (154361-50-9) Available for sale

Introduction to Capecitabine (154361-50-9): Understanding its Mechanism Capecitabine, a prodrug with the chemical formula C₁₅H₂₂FN₃O₆, is a cornerstone in cancer treatment, particularly for colorectal and breast cancers. Learn how this ingenious compound converts into its active form, 5-fluorouracil, to combat tumor growth.

The Chemistry Behind Capecitabine (154361-50-9): Unveiling its Molecular Structure Delve into the intricate molecular structure of Capecitabine, deciphering the bonds and arrangements that enable its targeted action against cancer cells while minimizing adverse effects on healthy tissues.

Exploring the Pharmacokinetics of Capecitabine (154361-50-9): From Ingestion to Metabolism Trace the journey of Capecitabine through the body, from its oral administration to its conversion into active metabolites, illuminating the factors influencing its absorption, distribution, metabolism, and excretion.

Capecitabine (154361-50-9): A Beacon of Hope in Colorectal Cancer Therapy Dive into the clinical efficacy of Capecitabine as a frontline therapy for colorectal cancer, elucidating its role in adjuvant and metastatic settings and its contribution to improved patient outcomes.

Harnessing Capecitabine (154361-50-9) in Breast Cancer Management: A Multifaceted Approach Explore the diverse applications of Capecitabine in breast cancer treatment, ranging from neoadjuvant and adjuvant therapy to its use in metastatic settings, unraveling its impact on disease progression and survival rates.

The Therapeutic Landscape of Capecitabine (154361-50-9): Navigating Adverse Effects Navigate through the potential adverse effects associated with Capecitabine therapy, from gastrointestinal disturbances to hand-foot syndrome, and explore strategies for their mitigation and management.

Unveiling the Clinical Trials of Capecitabine (154361-50-9): Pioneering Innovations in Cancer Care Track the evolution of Capecitabine through pivotal clinical trials, highlighting its efficacy and safety profiles across various cancer types and shedding light on emerging research avenues.

Capecitabine (154361-50-9) and Personalized Medicine: Tailoring Treatment to Individual Needs Explore the role of Capecitabine in the era of personalized medicine, where genetic biomarkers guide treatment decisions, optimizing therapeutic outcomes and minimizing treatment-related toxicity.

Combination Therapies with Capecitabine (154361-50-9): Enhancing Efficacy Through Synergistic Approaches Investigate the synergistic potential of Capecitabine in combination with other anticancer agents, such as oxaliplatin and trastuzumab, elucidating how these regimens enhance treatment response and prolong survival.

Future Perspectives on Capecitabine (154361-50-9): Innovations Shaping Tomorrow's Cancer Therapies Peer into the future of Capecitabine research, from novel drug delivery systems to targeted therapies, envisioning how continued advancements will revolutionize cancer treatment paradigms and improve patient outcomes.